Article | July 12, 2023

Advances In Antibody Therapeutics Depend On Resin Innovation

Purolite Image 1

As antibody therapeutics transforms health care and treatments for diseases such as cancer and autoimmune disorders, the biotech and pharmaceutical companies are making significant investments to meet a growing demand. The global market for monoclonal antibodies is currently forecasted to reach $647 billion by 2032.

Chromatographic resins are important in the development of antibody therapeutics because they separate and purify monoclonal antibodies from the proteins, DNA, and impurities that are part of the development process. Thanks to new products such as Praesto Jetted A50 HipH from Purolite, steps are being taken forward with Protein A resin technology that will help address resin availability and other concerns.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online

Purolite, An Ecolab Company